1-3 of 3
Naresh Bellam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia

Douglas Gladstone, MD, Marc Andre, MD PhD, Jan Zaucha, MD PhD, Sarit Assouline, MD MSc, Naresh Bellam, MD MPH, Nicole Cascavilla, MD, Eric Jourdan, MD PhD, Amit Panwalkar, MD, Caterina Patti, MD, Clemens Schulte, MD, Francesco Zaja, MD, Trishna Goswami, MD, Nairouz Elgeioushi, MPH, Katie Streicher, PhD, Haifeng Bao, PhD, David Spaner, MD FRCPC, PhD
Journal: Blood
Blood (2014) 124 (21): 4472.
https://doi.org/10.1182/blood.V124.21.4472.4472
Published: 2014
Journal Articles

Disseminated fusariosis during acute myelogenous leukemia induction treatment

Amitkumar Mehta, Naresh Bellam
Journal: Blood
Blood (2014) 123 (22): 3379.
https://doi.org/10.1182/blood-2014-02-556654
Published: 2014
Journal Articles

Phase 1b Study of TRU-016, an Anti-CD37 SMIP™ Protein, in Combination with Rituximab and Bendamustine in Relapsed Indolent Lymphoma

Ajay K. Gopal, MD, Stefano R Tarantolo, Naresh Bellam, MD, MPH, Tatyana Feldman, MD, Anthony R Mato, MD, Damian J Green, MD, Melissa Griffin, Scott Stromatt, MD, Andre Goy, MD
Journal: Blood
Blood (2012) 120 (21): 3678.
https://doi.org/10.1182/blood.V120.21.3678.3678
Published: 2012